This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

BioTalk

MvH

Maud van Haaren

Associate, Bird & Bird

10/27/2025 11:54:53 AM

By Pieter Erasmus Maud van Haaren Hester Borgers

The EU regulatory landscape for medical devices making use of artificial intelligence (MDAI) has become significantly more complex with...

5/1/2025 8:15:08 AM

By Emma Stok Hester Borgers Maud van Haaren +1 more...

Back in July 2023, the European Commission adopted a proposal for a regulation on plants obtained by new genomic techniques (NGTs). This...

2/26/2025 11:05:28 AM

By Sabrina Lodder Maud van Haaren

The Netherlands Food and Consumer Product Safety Authority (NVWA) has recently published regulatory guidance, introducing two new...

1/30/2025 9:28:21 AM

By Hester Borgers Maud van Haaren

The Dutch Medicines Evaluation Board (MEB) has recently published a new policy for Compassionate Use Programmes (CUP).[1] To support the...

1/22/2025 11:28:54 AM

By Hester Borgers Maud van Haaren

On 9 September 2024 the European Medicines Agency (“EMA”) issued its final reflection paper on the use of AI in the medicinal product...